Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$3.67
+0.00%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+36.2%
Consensus $5.00 vs current $3.67
NASDAQ·Healthcare·Biotechnology
$3.67
+0.00%
Mkt Cap $14.65M
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
+36.2%
Consensus $5.00 vs current $3.67